Literature DB >> 11668476

Restoration of endogenous wild-type p53 activity in a glioblastoma cell line with intrinsic temperature-sensitive p53 induces growth arrest but not apoptosis.

J Ikeda1, M Tada, N Ishii, H Saya, K Tsuchiya, K Okaichi, K Mishima, Y Sawamura, G Fulci, T J Liu, E G Van Meir.   

Abstract

p53 protein is a transcription factor involved in multiple tumor-suppressor activities including cell cycle control and apoptosis. TP53 gene is frequently mutated in glioblastoma, suggesting the importance of inactivation of this gene product in gliomagenesis. Restoration of p53 function in glioblastoma cell lines deficient for p53 has shown that p53 induces growth arrest or apoptosis depending on the cell line and vector used to transduce wild-type TP53 alleles. Considering that astrocytes grow and express p53, it is not clear whether these results reflect physiologic responses or the result of p53 overexpression in combination with cellular responses to viral vector infection. Here, we reassessed this issue using a glioblastoma cell line (LN382) that expresses an endogenous temperature-sensitive mutant p53. This cell line expresses TP53 alleles (100% as determined by a p53 transcriptional assay in yeast) mutated at codon 197 GTG (Val) > CTG (Leu). We found that the p53 protein in these cells acted as an inactive mutant at 37 degrees C and as a functional wild-type p53 below 34 degrees C as demonstrated by several lines of evidence, including (i) restoration of transactivating ability in yeast, (ii) induction of p53-modulated genes such as CDKN1(p21) and transforming growth factor-alpha, (iii) disappearance of accumulated p53 protein in the nucleus and (iv) decrease in steady state p53 protein levels. This temperature switch allowed p53 levels, which were close to physiological levels to dramatically reduce LN382 cell proliferation by inducing a G(1)/S cell cycle block, but not to induce apoptosis. The lack of apoptosis was considered to be a result of the low level p53 expression, because increasing wild-type p53 levels by adenoviral-mediated gene transfer caused apoptosis in these cells. The LN382 cell line will be extremely useful for investigations into the roles of p53 in cellular responses to a variety of stimuli or damages. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668476      PMCID: PMC2819747          DOI: 10.1002/ijc.1431

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

1.  Retrovirus-mediated p53 gene therapy.

Authors:  A Estreicher; R Iggo
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

2.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

3.  p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.

Authors:  T H Shin; A J Paterson; J E Kudlow
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

4.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

5.  Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay.

Authors:  M Tada; R D Iggo; N Ishii; Y Shinohe; S Sakuma; A Estreicher; Y Sawamura; H Abe
Journal:  Int J Cancer       Date:  1996-07-29       Impact factor: 7.396

6.  Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas.

Authors:  Y Iwadate; S Fujimoto; M Tagawa; H Namba; K Sueyoshi; M Hirose; S Sakiyama
Journal:  Int J Cancer       Date:  1996-06-21       Impact factor: 7.396

7.  A simple p53 functional assay for screening cell lines, blood, and tumors.

Authors:  J M Flaman; T Frebourg; V Moreau; F Charbonnier; C Martin; P Chappuis; A P Sappino; I M Limacher; L Bron; J Benhattar
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.

Authors:  A Goga; X Liu; T M Hambuch; K Senechal; E Major; A J Berk; O N Witte; C L Sawyers
Journal:  Oncogene       Date:  1995-08-17       Impact factor: 9.867

9.  Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53.

Authors:  K Forrester; S Ambs; S E Lupold; R B Kapust; E A Spillare; W C Weinberg; E Felley-Bosco; X W Wang; D A Geller; E Tzeng; T R Billiar; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53.

Authors:  R A Gjerset; S T Turla; R E Sobol; J J Scalise; D Mercola; H Collins; P J Hopkins
Journal:  Mol Carcinog       Date:  1995-12       Impact factor: 4.784

View more
  2 in total

1.  Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression.

Authors:  Balveen Kaur; Daniel J Brat; Cathárine C Calkins; Erwin G Van Meir
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

2.  Novel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors.

Authors:  Sanna-Maria Hede; Inga Nazarenko; Monica Nistér; Mikael S Lindström
Journal:  J Oncol       Date:  2010-12-15       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.